The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Manufacturers - Other > Lorus Therapeutics Inc.

Lorus Therapeutics Inc.
OTC: LORFF
Change
symbol:
     
 PROFILE
Lorus Therapeutics, formerly Imutec Pharma, is a warrior in the battle against cancer. The firm is developing antisense, immunotherapy, and chemotherapy technologies for cancer treatment; it is focusing on product that will have fewer adverse side effects than more traditional treatments. Products in development include Virulizin, an immunotherapeutic pancreatic cancer treatment; and NC-381, a chemotherapeutic drug the firm is developing in collaboration with the US National Cancer Institute. Lorus bought Canadian antisense technology developer GeneSense Technologies to expand its product pipeline. Lorus has signed a collaboration agreement with US-based AVI BioPharma.

 COMPETITION
Celgene Corporation (CELG)
Genta Incorporated (GNTA)
Hybridon, Inc. (HYBN)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: May
2000 Sales (mil.): 0.00
Employees: 21
Revenue per employee: $0.00

 KEY PEOPLE
• Jim A. Wright
    CEO
• James T. Parsons
    CFO

 CONTACT INFO
7100 Woodbine Ave., Ste. 215
Markham Ontario L3R 5J2, Canada
Phone: 1-905-305-1100
Fax: 1-905-305-1584
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001